Integration of deworming into HIV care and treatment: A neglected opportunity

PLoS Neglected Tropical Diseases

Volumn 6, Issue 7, 2012, Pages

  Gerns, Helen L ^a   Sangaré, Laura R ^a   Walson, Judd L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIPARASITIC AGENT;

AFRICA; ANTIBODY TITER; ARTICLE; HELMINTHIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; RISK; SINGLE DRUG DOSE; WORLD HEALTH ORGANIZATION; WORM EXPULSION; ADOLESCENT; AFRICA SOUTH OF THE SAHARA; CHILD; FEMALE; MALE; PARASITOSIS; PRESCHOOL CHILD;

ADOLESCENT; AFRICA SOUTH OF THE SAHARA; ANTIPARASITIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; MALE; PARASITIC DISEASES;

EID: 84864577560     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001738     Document Type: Article

References (24)

1. UNAIDS (2008) HIV and AIDS estimates and data, 2007 and 2001. 2008 Report on the global AIDS epidemic. Geneva: UNAIDS.
2. Brooker S, Clements ACA, Bundy DAP (2006) Global epidemiology, ecology and control of soil-transmitted helminth infections. In: Advances in parasitology. Simon I, Hay AG, David JR, editors. Academic Press. 221-261.
3. Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, et al. ((2006)) Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 367:: 1521--1532.
4. Moreau E, Chauvin A, ((2010)) Immunity against helminths: interactions with the host and the intercurrent infections. J Biomed Biotechnol 2010:: 428593.
5. Blish CA, Sangare L, Herrin BR, Richardson BA, John-Stewart G, et al. ((2010)) Changes in plasma cytokines after treatment of ascaris lumbricoides infection in individuals with HIV-1 infection. J Infect Dis 201:: 1816--1821.
6. Sangare LR, Herrin BR, John-Stewart G, Walson JL, ((2011)) Species-specific treatment effects of helminth/HIV-1 co-infection: a systematic review and meta-analysis. Parasitology 138:: 1546--1558.
7. Walson JL, Herrin BR, John-Stewart G, ((2009)) Deworming helminth co-infected individuals for delaying HIV disease progression. Cochrane Database Syst Rev pp. CD006419.
8. Walson JL, Otieno PA, Mbuchi M, Richardson BA, Lohman-Payne B, et al. ((2008)) Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial. AIDS 22:: 1601--1609.
9. Walson JL, John-Stewart G, ((2007)) Treatment of helminth co-infection in individuals with HIV-1: A systematic review of the literature. PLoS Negl Trop Dis 1:: e102 doi:10.1371/journal.pntd.0000102.
10. Levine MM, ((2010)) Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biology 8.
11. Walker CLF, Black RE, ((2011)) Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size. BMC Public Health 11.
12. Grassly NC, Fraser C, Wenger J, Deshpande JM, Sutter RW, et al. ((2006)) New strategies for the elimination of polio from India. Science 314:: 1150--1153.
13. Labeaud AD, Malhotra I, King MJ, King CL, King CH, ((2009)) Do antenatal parasite infections devalue childhood vaccination? PLoS Negl Trop Dis 3:: e442 doi:10.1371/journal.pntd.0000442.
14. Elias D, Britton S, Aseffa A, Engers H, Akuffo H, ((2008)) Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production. Vaccine 26:: 3897--3902.
15. Noland GS, Chowdhury DR, Urban JF Jr, Zavala F, Kumar N, ((2010)) Helminth infection impairs the immunogenicity of a Plasmodium falciparum DNA vaccine, but not irradiated sporozoites, in mice. Vaccine 28:: 2917--2923.
16. Da'dara AA, Harn DA, ((2010)) Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10. Vaccine 28:: 1310--1317.
17. Triki H, Abdallah MV, Ben Aissa R, Bouratbine A, Ben Ali Kacem M, et al. ((1997)) Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants. Vaccine 15:: 1123--1129.
18. Cooper PJ, Chico ME, Losonsky G, Sandoval C, Espinel I, et al. ((2000)) Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR. J Infect Dis 182:: 1199--1206.
19. Roca A, Sigauque B, Quinto L, Morais L, Berenguera A, et al. ((2010)) Estimating the vaccine-preventable burden of hospitalized pneumonia among young Mozambican children. Vaccine 28:: 4851--4857.
20. Bekker V, Scherpbier H, Pajkrt D, Jurriaans S, Zaaijer H, et al. ((2006)) Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Pediatrics 118:: e315--e322.
21. Albonico M, Allen H, Chitsulo L, Engels D, Gabrielli AF, et al. ((2008)) Controlling soil-transmitted helminthiasis in pre-school-age children through preventive chemotherapy. PLoS Negl Trop Dis 2:: e126 doi:10.1371/journal.pntd.0000126.
22. WHO (2003) Report of the WHO informal consultation on the use of Praziquantel during pregnancy/lactation and albendazole/mebendazole in children under 24 months. Geneva: WHO.
23. Ndirangu J, Barnighausen T, Tanser F, Tint K, Newell ML, ((2009)) Levels of childhood vaccination coverage and the impact of maternal HIV status on child vaccination status in rural KwaZulu-Natal, South Africa*. Trop Med Int Health 14:: 1383--1393.
24. De Baets AJ, Bulterys M, Abrams EJ, Kankassa C, Pazvakavambwa IE, ((2007)) Care and treatment of HIV-infected children in Africa: issues and challenges at the district hospital level. Pediatr Infect Dis J 26:: 163--173.